Early research (Phase 1)Ended earlyNCT06420349
What this trial is testing
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
Who this might be right for
Advanced CholangiocarcinomaMetastatic CholangiocarcinomaRefractory Cholangiocarcinoma+4 more
Mayo Clinic 7